375 related articles for article (PubMed ID: 18511846)
1. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
Soro-Paavonen A; Watson AM; Li J; Paavonen K; Koitka A; Calkin AC; Barit D; Coughlan MT; Drew BG; Lancaster GI; Thomas M; Forbes JM; Nawroth PP; Bierhaus A; Cooper ME; Jandeleit-Dahm KA
Diabetes; 2008 Sep; 57(9):2461-9. PubMed ID: 18511846
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.
Walcher D; Marx N
Semin Immunopathol; 2009 Jun; 31(1):103-11. PubMed ID: 19347338
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling.
Gao H; Li H; Li W; Shen X; Di B
Med Sci Monit; 2017 Dec; 23():6121-6131. PubMed ID: 29278639
[TBL] [Abstract][Full Text] [Related]
4. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
5. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.
Lewis P; Stefanovic N; Pete J; Calkin AC; Giunti S; Thallas-Bonke V; Jandeleit-Dahm KA; Allen TJ; Kola I; Cooper ME; de Haan JB
Circulation; 2007 Apr; 115(16):2178-87. PubMed ID: 17420349
[TBL] [Abstract][Full Text] [Related]
6. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.
Bu DX; Rai V; Shen X; Rosario R; Lu Y; D'Agati V; Yan SF; Friedman RA; Nuglozeh E; Schmidt AM
Circ Res; 2010 Apr; 106(6):1040-51. PubMed ID: 20133903
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
8. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis.
Uekita H; Ishibashi T; Shiomi M; Koyama H; Ohtsuka S; Yamamoto H; Yamagishi S; Inoue H; Itabe H; Sugimoto K; Kamioka M; Ohkawara H; Wada I; Yasuchika T
Fukushima J Med Sci; 2019; 65(3):109-121. PubMed ID: 31915324
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
[TBL] [Abstract][Full Text] [Related]
10. Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice.
Watson AM; Li J; Samijono D; Bierhaus A; Thomas MC; Jandeleit-Dahm KA; Cooper ME
Atherosclerosis; 2014 Aug; 235(2):444-8. PubMed ID: 24945577
[TBL] [Abstract][Full Text] [Related]
11. Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.
Chew P; Yuen DY; Koh P; Stefanovic N; Febbraio MA; Kola I; Cooper ME; de Haan JB
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):823-30. PubMed ID: 19325139
[TBL] [Abstract][Full Text] [Related]
12. The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice.
Lu Y; Qin W; Shen T; Dou L; Man Y; Wang S; Xiao C; Li J
J Atheroscler Thromb; 2011; 18(11):998-1008. PubMed ID: 21873804
[TBL] [Abstract][Full Text] [Related]
13. SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis.
Terasaki M; Shibata K; Mori Y; Saito T; Matsui T; Ohara M; Fukui T; Hasumi K; Higashimoto Y; Nobe K; Yamagishi SI
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047475
[TBL] [Abstract][Full Text] [Related]
14. Effect of atorvastatin on AGEs-induced injury of cerebral cortex via inhibiting NADPH oxidase -NF-κB pathway in ApoE
Li Z; Yang P; Feng B
Mol Biol Rep; 2020 Dec; 47(12):9479-9488. PubMed ID: 33210255
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis.
Liu M; Yu Y; Jiang H; Zhang L; Zhang PP; Yu P; Jia JG; Chen RZ; Zou YZ; Ge JB
Acta Pharmacol Sin; 2013 Jun; 34(6):830-6. PubMed ID: 23564080
[TBL] [Abstract][Full Text] [Related]
16. Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice.
Watson AM; Gray SP; Jiaze L; Soro-Paavonen A; Wong B; Cooper ME; Bierhaus A; Pickering R; Tikellis C; Tsorotes D; Thomas MC; Jandeleit-Dahm KA
Diabetes; 2012 Aug; 61(8):2105-13. PubMed ID: 22698914
[TBL] [Abstract][Full Text] [Related]
17. Linking RAGE and Nox in diabetic micro- and macrovascular complications.
Koulis C; Watson AMD; Gray SP; Jandeleit-Dahm KA
Diabetes Metab; 2015 Sep; 41(4):272-281. PubMed ID: 26323666
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice.
Li P; Tang Z; Wang L; Feng B
Mol Med Rep; 2017 Sep; 16(3):3421-3426. PubMed ID: 28713911
[TBL] [Abstract][Full Text] [Related]
19. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
[TBL] [Abstract][Full Text] [Related]
20. PKCβ promotes vascular inflammation and acceleration of atherosclerosis in diabetic ApoE null mice.
Kong L; Shen X; Lin L; Leitges M; Rosario R; Zou YS; Yan SF
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1779-87. PubMed ID: 23766264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]